Nanoscale regulation of L-type calcium channels differentiates between ischemic and dilated cardiomyopathies

EBioMedicine. 2020 Jul:57:102845. doi: 10.1016/j.ebiom.2020.102845. Epub 2020 Jun 21.

Abstract

Background: Subcellular localization and function of L-type calcium channels (LTCCs) play an important role in regulating contraction of cardiomyocytes. Understanding how this is affected by the disruption of transverse tubules during heart failure could lead to new insights into the disease.

Methods: Cardiomyocytes were isolated from healthy donor hearts, as well as from patients with cardiomyopathies and with left ventricular assist devices. Scanning ion conductance and confocal microscopy was used to study membrane structures in the cells. Super-resolution scanning patch-clamp was used to examine LTCC function in different microdomains. Computational modeling predicted the impact of these changes to arrhythmogenesis at the whole-heart level.

Findings: We showed that loss of structural organization in failing myocytes leads to re-distribution of functional LTCCs from the T-tubules to the sarcolemma. In ischemic cardiomyopathy, the increased LTCC open probability in the T-tubules depends on the phosphorylation by protein kinase A, whereas in dilated cardiomyopathy, the increased LTCC opening probability in the sarcolemma results from enhanced phosphorylation by calcium-calmodulin kinase II. LVAD implantation corrected LTCCs pathophysiological activity, although it did not improve their distribution. Using computational modeling in a 3D anatomically-realistic human ventricular model, we showed how LTCC location and activity can trigger heart rhythm disorders of different severity.

Interpretation: Our findings demonstrate that LTCC redistribution and function differentiate between disease aetiologies. The subcellular changes observed in specific microdomains could be the consequence of the action of distinct protein kinases.

Funding: This work was supported by NIH grant (ROI-HL 126802 to NT-JG) and British Heart Foundation (grant RG/17/13/33173 to JG, project grant PG/16/17/32069 to RAC). Funders had no role in study design, data collection, data analysis, interpretation, writing of the report.

Keywords: Cardiomyopathy; Computational biology; Electrophysiology; Heart Failure; Ion channels.

MeSH terms

  • Aged
  • Calcium / metabolism
  • Calcium Channels, L-Type / genetics*
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / genetics*
  • Cardiomyopathy, Dilated / genetics*
  • Cardiomyopathy, Dilated / metabolism
  • Cardiomyopathy, Dilated / pathology
  • Cyclic AMP-Dependent Protein Kinases / genetics*
  • Female
  • Heart Failure / genetics
  • Heart Failure / pathology
  • Heart Transplantation / adverse effects
  • Heart Ventricles / metabolism
  • Heart Ventricles / pathology
  • Heart Ventricles / ultrastructure
  • Humans
  • Male
  • Middle Aged
  • Myocardial Ischemia / genetics*
  • Myocardial Ischemia / metabolism
  • Myocardial Ischemia / pathology
  • Myocytes, Cardiac / metabolism
  • Myocytes, Cardiac / pathology
  • Sarcolemma / genetics
  • Sarcolemma / pathology
  • Tissue Donors
  • Ventricular Dysfunction, Left / genetics
  • Ventricular Dysfunction, Left / metabolism
  • Ventricular Dysfunction, Left / pathology

Substances

  • Calcium Channels, L-Type
  • Cyclic AMP-Dependent Protein Kinases
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Calcium